Why Pharma Is Increasingly Outsourcing Manufacturing to CDMOs 2026
Outsourcing pharmaceutical manufacturing has become a strategic imperative for pharma companies in 2026. As pipelines shift toward complex formulations, biologics, and niche products, many sponsors lack the internal infrastructure required for formulation development, technology transfer, and compliant scale-up. The global CDMO market is projected to grow from USD 255.01 billion in 2025 to USD 465.24 […]